Surface-modified gatifloxacin nanoparticles with potential for treating central nervous system tuberculosis
Patricia Marcianes,1 Sofia Negro,1,2 Luis García-García,3 Consuelo Montejo,4 Emilia Barcia,1,2 Ana Fernández-Carballido1,2 1Department of Pharmaceutics, School of Pharmacy, University Complutense of Madrid, Madrid, Spain; 2Institute of Pharmaceutical Technology, Uni...
Guardado en:
Autores principales: | Marcianes P, Negro S, García-García L, Montejo C, Barcia E, Fernández-Carballido A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/da8a6987a11445bebf783069b7dd4127 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases
por: Claudia Riccardi, et al.
Publicado: (2021) -
In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin
por: Ashrafzadeh MS, et al.
Publicado: (2020) -
c(RGDyK)-decorated Pluronic micelles for enhanced doxorubicin and paclitaxel delivery to brain glioma
por: Huang YK, et al.
Publicado: (2016) -
Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours
por: Ferraris C, et al.
Publicado: (2020) -
In-vivo thrombolytic efficacy of RGD modified protein-polymer conjugated urokinase nanogels
por: Xia Liu, et al.
Publicado: (2021)